Literature DB >> 18383336

Allosteric kinetics of human carboxylesterase 1: species differences and interindividual variability.

Shiori Takahashi1, Miki Katoh, Takashi Saitoh, Miki Nakajima, Tsuyoshi Yokoi.   

Abstract

Esterified drugs such as imidapril, derapril, and oxybutynin hydrolyzed by carboxylesterase 1 (CES1) are extensively used in clinical practice. The kinetics using the CES1 substrates have not fully clarified, especially concerning species and tissue differences. In the present study, we performed the kinetic analyses in humans and rats in order to clarify these differences. The imidaprilat formation from imidapril exhibited sigmoidal kinetics in human liver microsomes (HLM) and cytosol (HLC) but Michaelis-Menten kinetics in rat liver microsomes and cytosol. The 2-cyclohexyl-2-phenylglycolic acid (CPGA) formation from oxybutynin were not detected in enzyme sources from rats, although HLM showed high activity. The kinetics were clarified to be different among species, tissues, and preparations. In individual HLM and HLC, there was large interindividual variability in imidaprilat (31- and 24-fold) and CPGA formations (15- and 9-fold). Imidaprilat formations exhibited Michaelis-Menten kinetics in HLM and HLC with high activity but sigmoidal kinetics in those with low activity. CPGA formations showed sigmoidal kinetics in high activity HLM but Michaelis-Menten kinetics in HLM with low activity. We revealed that the kinetics were different between individuals. These results could be useful for understanding interindividual variability and for the development of oral prodrugs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18383336     DOI: 10.1002/jps.21376

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Multicolor imaging of endoplasmic reticulum-located esterase as a prodrug activation enzyme.

Authors:  Wataru Hakamata; Saori Tamura; Takako Hirano; Toshiyuki Nishio
Journal:  ACS Med Chem Lett       Date:  2014-01-16       Impact factor: 4.345

2.  Dexamethasone regulates differential expression of carboxylesterase 1 and carboxylesterase 2 through activation of nuclear receptors.

Authors:  Chengliang Zhang; Ping Gao; Weifeng Yin; Yanjiao Xu; Daochun Xiang; Dong Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-12-28

3.  Rapalogues as hCES2A Inhibitors: In Vitro and In Silico Investigations.

Authors:  Cheng-Cheng Shi; Yun-Qing Song; Rong-Jing He; Xiao-Qing Guan; Li-Lin Song; Shi-Tong Chen; Meng-Ru Sun; Guang-Bo Ge; Li-Rong Zhang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-01       Impact factor: 2.441

4.  Effect of carboxylesterase 1 S75N on clopidogrel therapy among acute coronary syndrome patients.

Authors:  Fei-Yan Xiao; Jian-Quan Luo; Min Liu; Bi-Lian Chen; Shan Cao; Zhao-Qian Liu; Hong-Hao Zhou; Gan Zhou; Wei Zhang
Journal:  Sci Rep       Date:  2017-08-03       Impact factor: 4.379

5.  In vitro evaluation of the inhibitory potential of pharmaceutical excipients on human carboxylesterase 1A and 2.

Authors:  Chengliang Zhang; Yanjiao Xu; Qiaoni Zhong; Xiping Li; Ping Gao; Chengyang Feng; Qian Chu; Yuan Chen; Dong Liu
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

6.  Comparison of the Structure and Activity of Glycosylated and Aglycosylated Human Carboxylesterase 1.

Authors:  Victoria Arena de Souza; David J Scott; Joanne E Nettleship; Nahid Rahman; Michael H Charlton; Martin A Walsh; Raymond J Owens
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

Review 7.  Human carboxylesterases: a comprehensive review.

Authors:  Dandan Wang; Liwei Zou; Qiang Jin; Jie Hou; Guangbo Ge; Ling Yang
Journal:  Acta Pharm Sin B       Date:  2018-06-25       Impact factor: 11.413

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.